查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2018-2028年再生性伤口护理市场-全球行业规模、份额、趋势、机会和预测，按类型、伤口类型、终端用户、区域和竞争情况划分
市场调查报告书
商品编码
1303143

2018-2028年再生性伤口护理市场-全球行业规模、份额、趋势、机会和预测，按类型、伤口类型、终端用户、区域和竞争情况划分

Regenerative Wound Care Market-Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type, By Wound Type, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 118 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球再生性伤口护理市场是由烧伤、受伤、烧伤和溃疡等引起的伤口发生率不断增加所推动的。此外，日益增长的老年人口容易受到各种伤害和跌倒，预计将增加对再生伤口护理市场的需求。在老年人口中，由于各种其他相关条件，伤口愈合过程缓慢，导致对能够带来更快的伤口愈合的产品的需求，从而支持市场增长。根据联合国经济和社会事务部人口司的数据，到2050年，65岁或以上的人口数量预计将达到15.489亿。

糖尿病病例不断增加

糖尿病的发病率不断增加，预计将增加对再生性伤口护理的需求。在包括中国和印度在内的几个发展中国家，糖尿病已经成为一种流行病。糖尿病会增加伤口的总体发病率和复杂性，特别是感染、慢性伤口和溃疡。这需要治疗并产生高昂的医疗费用。世界卫生组织（WHO）报告称，2019年非传染性疾病造成74%的死亡；糖尿病造成160万人死亡，是全球第九大死因。在全球范围内以及像印度这样的新兴国家，糖尿病的负担很大，而且还在上升，主要是由于超重/肥胖率上升和不健康的生活方式。众多因素，如异常的高血糖，可能会损害血管和神经。这减少了流向手、脚和腿的血流量，这使得伤口和溃疡更难愈合。美国疾病控制和预防中心（CDC）估计，在美国约有3730万人患有糖尿病，占人口的11.3%。糖尿病还可能导致糖尿病神经病变，从而影响伤口愈合。

烧伤、事故、伤害的发生率增加

由于手术、事故和受伤等原因造成的伤口发生率不断增加，大大增加了对再生性伤口护理的需求。全球第十大死因是道路交通事故，这也是最常见的，因为有几个因素，如超速；在酒精和其他精神活性物质影响下驾驶；不使用摩托车头盔、安全带和儿童安全座椅；分心驾驶；不安全的车辆；碰撞后护理不足和交通法规执法不力。世卫组织估计，每年有130多万人因道路交通事故而丧生。另有2000万至5000万人受到非致命性伤害，其中许多人因此而成为残疾人。

最近的发展情况

全球再生性伤口护理市场正在见证许多新的发展，包括合并和收购、推出新产品、启动新的临床试验、增加研发活动和进行投资等，以保持竞争力，并在市场上的其他参与者中占据优势。

  • 2021年6月，MiMedx Group, Inc.获得日本厚生劳动省批准其产品Epifix在日本进行商业化。
  • 2019年5月，Organogenesis Inc.与Vizient, Inc.达成了一项协议。这又帮助Organogenesis公司增加了其伤口护理产品的供应，提高了其市场定位。

可用的定制服务

利用给定的市场数据，TechSci Research根据公司的具体需求提供定制服务。该报告有以下定制选项：

公司信息

  • 其他市场参与者（最多5家）的详细分析和概况。

目录

第一章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 研究考虑的年份
    • 关键的市场细分

第二章：研究方法

  • 研究的目的
  • 基线方法
  • 主要行业合作伙伴
  • 主要协会和二级来源
  • 预测方法
  • 数据三角测量和验证
  • 假设和限制

第三章：执行摘要

  • 市场概述
  • 主要市场细分概述
  • 主要市场参与者概述
  • 主要地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第四章：客户的声音

第五章：临床试验分析

  • 正在进行的临床试验
  • 已完成的临床试验
  • 终止的临床试验
  • 按开发阶段分類的管线细目
  • 按状态分类的管线细目
  • 按研究应用分类的管线细目
  • 按地区分类的管线细目
  • 临床试验热图

第六章：全球再生性伤口护理市场展望

  • 市场规模和预测
    • 按价值
  • 市场份额与预测
    • 按类型（自体干细胞、生物皮肤替代品、组织/多组织平台、胎儿皮肤、再生伤口护理设备、其他）分类
    • 按伤口类型（溃疡、手术和创伤性伤口、烧伤）分类
    • 按终端用户（医院、非住院手术中心、烧伤护理中心和伤口诊所、其他）分类
    • 按地区分类
    • 按公司分类(2022年)
  • 市场地图

第七章：北美再生性伤口护理市场展望

  • 市场规模和预测
    • 按价值分类
  • 市场份额与预测
    • 按类型（自体干细胞、生物皮肤替代品、组织/多组织平台、胎儿皮肤、设备、其他）分类
    • 按伤口类型（溃疡、手术和创伤性伤口、烧伤）分类
    • 按终端用户（医院、非住院手术中心、烧伤护理中心和伤口诊所、其他）分类
    • 按国家分类
  • 北美洲：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第8章：欧洲再生性伤口护理市场前景

  • 市场规模和预测
    • 按价值计算
  • 市场份额与预测
    • 按类型（自体干细胞、生物皮肤替代品、组织/多组织平台、胎儿皮肤、设备、其他）分类
    • 按伤口类型（溃疡、手术和创伤性伤口、烧伤）分类
    • 按终端用户（医院、非住院手术中心、烧伤护理中心和伤口诊所、其他）分类
    • 按国家分类
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第九章：亚太地区再生性伤口护理市场展望

  • 市场规模和预测
    • 按价值计算
  • 市场份额与预测
    • 按类型（自体干细胞、生物皮肤替代品、组织/多组织平台、胎儿皮肤、设备、其他）分类
    • 按伤口类型（溃疡、手术和创伤性伤口、烧伤）分类
    • 按终端用户（医院、非住院手术中心、烧伤护理中心和伤口诊所、其他）分类
    • 按国家分类
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第十章：南美再生性伤口护理市场前景

  • 市场规模和预测
    • 按价值计算
  • 市场份额与预测
    • 按类型（自体干细胞、生物皮肤替代品、组织/多组织平台、胎儿皮肤、设备、其他）分类
    • 按伤口类型（溃疡、手术和创伤性伤口、烧伤）分类
    • 按终端用户（医院、非住院手术中心、烧伤护理中心和伤口诊所、其他）分类
    • 按国家分类
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第11章 ：中东和非洲再生性伤口护理市场展望

  • 市场规模和预测
    • 按价值计算
  • 市场份额与预测
    • 按类型（自体干细胞、生物皮肤替代品、组织/多组织平台、胎儿皮肤、再生伤口护理设备、其他）分类
    • 按伤口类型（溃疡、手术和创伤性伤口、烧伤）分类
    • 按终端用户（医院、非住院手术中心、烧伤护理中心和伤口诊所、其他）分类
    • 按国家分类
  • MEA: 国家分析
    • 南非 再生性伤口护理
    • 沙特阿拉伯 再生性伤口护理
    • 阿联酋 再生性伤口护理

第十二章 ：市场动态

  • 驱动力
  • 挑战

第十三章 ：市场趋势与发展

  • 最近的发展情况
  • 合併和收购
  • 产品发布

第十四章：竞争格局

  • 业务概况 公司简介 产品与服务 财务状况（如报告所示） 近期发展 SWOT分析
    • DeCell Technologies Inc.
    • Avita Medical, Inc.
    • Organogenesis, Inc.
    • Histogen, Inc.
    • RenovoDerm (Nanofiber Solutions, LLC)
    • StemsysBio
    • Koninklijke DSM N.V.
    • MiMedx Group, Inc.

第十五章：战略建议

简介目录
Product Code: 14405

Global Regenerative Wound Care Market is driven by the growing incidence of wounds caused due to burns, injuries, soars & ulcers, among others. Additionally, a growing geriatric population that is susceptible to various kinds of injuries and falls is expected to increase the demand for the regenerative wound care market. In the elderly population, due to various other associated conditions, the wound healing process is slow, leading to the demand for products that can bring about faster wound healing, thereby supporting market growth. According to the United Nations Department of Economic and Social Affairs, Population Division, the number of persons aged 65 years or above is expected to reach 1548.9 million by 2050.

The growing number of surgical procedures performed, along with increasing incidences of chronic burns, is further expected to increase the demand for the regenerative wound care market. Furthermore, the growing prevalence of diabetes is expected to fuel market growth in the coming years. Moreover, increasing research & development and new product approvals & launches are further expected to create lucrative opportunities for market growth. According to clinicaltrials.gov, as of 12th December, there are around 57 clinical trials registered across the globe related to regenerative wound care, which is in different phases of development worldwide. This, in turn, has led to the development and launch of new products. Organogenesis, Inc. was the first company to receive FDA approvals for a living, human cell-based product, Apligraf, and Dermagraft.

Apligraf is bioengineered with living cells that are bioactive to transform wounds from chronic to acute. Apligraf has illustrated clinical evidence in the treatment of Healing Venous Leg Ulcers and Diabetic Foot Ulcers. Apligraf resembles and functions like healthy human skin. Similarly, Dermagraft is a sterile, cryopreserved, human fibroblast-derived dermal substitute generated by the culture of neonatal dermal fibroblasts onto a bioabsorbable polyglactin mesh scaffold for the treatment of Diabetic Foot Ulcer in the United States.

Increasing cases of diabetes

The growing prevalence of diabetes is expected to increase the demand for regenerative wound care. Diabetes has become a pandemic in several developing nations, including China and India. Diabetes can increase the overall incidence and complexity of wounds, especially infections, chronic wounds, and ulcerations. This requires treatment and incurs exorbitant medical expenses. The World Health Organization (WHO) reports that non-communicable diseases caused 74% of deaths in 2019; diabetes killed 1.6 million people, making it the ninth largest cause of death worldwide. Globally and in emerging nations like India, the burden of diabetes is large and rising, primarily due to rising rates of overweight/obesity and unhealthy lifestyles. Numerous factors, such as abnormally high blood sugar, might damage blood vessels and nerves. This reduces blood flow to the hands, feet, and legs, which makes it more difficult for cuts and sores to heal. The Centers for Disease Control and Prevention (CDC) estimates that about 37.3 million people in the United States, or 11.3% of the population, have diabetes. Diabetes can also cause diabetic neuropathy, which can affect wound healing.

Increase in Incidences of Burns, Accidents, Injuries

The growing incidences of wounds caused due to surgeries, accidents, and injuries, among others, have significantly increased the demand for regenerative wound care. The tenth biggest cause of death globally is road traffic accidents, which are also the most common due to several factors such as speeding; driving under the influence of alcohol and other psychoactive substances; no-use of motorcycle helmets, seatbelts, and child restraints; distracted driving; unsafe vehicle; inadequate post-crash care and inadequate law enforcement of traffic laws. The WHO estimates that every year road traffic accidents claim the lives of over 1.3 million people. Between 20 and 50 million additional people have non-fatal injuries, with many of them becoming disabled as a result.

Market Segmentation

Global Regenerative Wound Care Market can be segmented by type, by wound type, by end-user, and by region. Based on type, the market can be categorized into autologous stem cells, biological skin substitutes, tissue/multiple tissue platforms, fetal skin, regenerative wound care devices, and others. Based on wound type, the market can be fragmented into ulcers, surgical & traumatic wounds, and burns. Ulcers can further be divided into diabetic foot ulcers, pressure ulcers, and others. Based on end-user, the market can be grouped into hospitals, ambulatory surgical centers, burn care centers & wound clinics, and others. Regionally, the market can be segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

Market Players

DeCell Technologies Inc., Avita Medical, Inc., Organogenesis, Inc., Histogen, Inc., RenovoDerm (Nanofiber Solutions, LLC), StemsysBio, Koninklijke DSM N.V., MiMedx Group, Inc., among others, are some of the leading players operating in the global regenerative wound care market.

Recent Developments

Global Regenerative Wound Care Market is witnessing a lot of new developments in the form of mergers & acquisitions, new product launches, launching new clinical trials, increasing research & development activities, and making investments, among others, in order to stay competitive and an edge over the other players operating in the market.

  • In June 2021, MiMedx Group, Inc. received approval for the commercialization of its product Epifix in Japan from the Japanese Ministry of Health, Labour, and Welfare.
  • In May 2019, Organogenesis Inc. entered into an agreement with Vizient, Inc. This, in turn, helped Organogenesis increase its wound care product offerings and improve its market positioning.

Report Scope

In this report, Global Regenerative Wound Care Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Regenerative Wound Care Market, By type:

  • Autologous Stem Cells
  • Biological Skin Substitutes
  • Tissue/Multiple Tissue Platform
  • Fetal Skin
  • Regenerative Wound Care Devices
  • Others

Regenerative Wound Care Market, By Wound Type:

  • Ulcers
  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Others
  • Surgical & Traumatic Wounds
  • Burns

Regenerative Wound Care Market, By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Burn Care Centers & Wound Clinics
  • Others

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Regenerative Wound Care Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

  • 5.1. Ongoing Clinical Trials
  • 5.2. Completed Clinical Trials
  • 5.3. Terminated Clinical Trials
  • 5.4. Breakdown of Pipeline, By Development Phase
  • 5.5. Breakdown of Pipeline, By Status
  • 5.6. Breakdown of Pipeline, By Study Application
  • 5.7. Breakdown of Pipeline, By Region
  • 5.8. Clinical Trials Heat Map

6. Global Regenerative Wound Care Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Autologous Stem Cells, Biological Skin Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative Wound Care Devices, Others)
    • 6.2.2. By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns)
      • 6.2.2.1. By Ulcers (Diabetic Foot Ulcers, Pressure Ulcers, Others)
    • 6.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Burn Care Centers & Wound Clinics, Others)
    • 6.2.4. By Region
    • 6.2.5. By Company (2022)
  • 6.3. Market Map

7. North America Regenerative Wound Care Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Autologous Stem Cells, Biological Skin Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative Wound Care Devices, Others)
    • 7.2.2. By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns)
      • 7.2.2.1. By Ulcers (Diabetic Foot Ulcers, Pressure Ulcers, Others)
    • 7.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Burn Care Centers & Wound Clinics, Others)
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Regenerative Wound Care Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Wound Type
        • 7.3.1.2.3. By End User
    • 7.3.2. Canada Regenerative Wound Care Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Wound Type
        • 7.3.2.2.3. By End User
    • 7.3.3. Mexico Regenerative Wound Care Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Wound Type
        • 7.3.3.2.3. By End User

8. Europe Regenerative Wound Care Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. B By Type (Autologous Stem Cells, Biological Skin Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative Wound Care Devices, Others)
    • 8.2.2. By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns)
      • 8.2.2.1. By Ulcers (Diabetic Foot Ulcers, Pressure Ulcers, Others)
    • 8.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Burn Care Centers & Wound Clinics, Others)
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Regenerative Wound Care Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Wound Type
        • 8.3.1.2.3. By End User
    • 8.3.2. Germany Regenerative Wound Care Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Wound Type
        • 8.3.2.2.3. By End User
    • 8.3.3. United Kingdom Regenerative Wound Care Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Wound Type
        • 8.3.3.2.3. By End User
    • 8.3.4. Italy Regenerative Wound Care Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Wound Type
        • 8.3.4.2.3. By End User
    • 8.3.5. Spain Regenerative Wound Care Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Wound Type
        • 8.3.5.2.3. By End User

9. Asia-Pacific Regenerative Wound Care Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Autologous Stem Cells, Biological Skin Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative Wound Care Devices, Others)
    • 9.2.2. By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns)
      • 9.2.2.1. By Ulcers (Diabetic Foot Ulcers, Pressure Ulcers, Others)
    • 9.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Burn Care Centers & Wound Clinics, Others)
    • 9.2.4. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Regenerative Wound Care Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Wound Type
        • 9.3.1.2.3. By End User
    • 9.3.2. India Regenerative Wound Care Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Wound Type
        • 9.3.2.2.3. By End User
    • 9.3.3. Japan Regenerative Wound Care Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Wound Type
        • 9.3.3.2.3. By End User
    • 9.3.4. South Korea Regenerative Wound Care Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Wound Type
        • 9.3.4.2.3. By End User
    • 9.3.5. Australia Regenerative Wound Care Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Wound Type
        • 9.3.5.2.3. By End User

10. South America Regenerative Wound Care Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Autologous Stem Cells, Biological Skin Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative Wound Care Devices, Others)
    • 10.2.2. By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns)
      • 10.2.2.1. By Ulcers (Diabetic Foot Ulcers, Pressure Ulcers, Others)
    • 10.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Burn Care Centers & Wound Clinics, Others)
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Regenerative Wound Care Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Wound Type
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina Regenerative Wound Care Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Wound Type
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia Regenerative Wound Care Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Wound Type
        • 10.3.3.2.3. By End User

11. Middle East and Africa Regenerative Wound Care Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type (Autologous Stem Cells, Biological Skin Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative Wound Care Devices, Others)
    • 11.2.2. By Wound Type (Ulcers, Surgical & Traumatic Wounds, Burns)
      • 11.2.2.1. By Ulcers (Diabetic Foot Ulcers, Pressure Ulcers, Others)
    • 11.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Burn Care Centers & Wound Clinics, Others)
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Regenerative Wound Care Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Wound Type
        • 11.3.1.2.3. By End User
    • 11.3.2. Saudi Arabia Regenerative Wound Care Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Wound Type
        • 11.3.2.2.3. By End User
    • 11.3.3. UAE Regenerative Wound Care Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Wound Type
        • 11.3.3.2.3. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Recent Developments
  • 13.2. Mergers & Acquisitions
  • 13.3. Product Launches

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Company Snapshot
  • 14.3. Products & Services
  • 14.4. Financials (As Reported)
  • 14.5. Recent Developments
  • 14.6. SWOT Analysis
    • 14.6.1. DeCell Technologies Inc.
    • 14.6.2. Avita Medical, Inc.
    • 14.6.3. Organogenesis, Inc.
    • 14.6.4. Histogen, Inc.
    • 14.6.5. RenovoDerm (Nanofiber Solutions, LLC)
    • 14.6.6. StemsysBio
    • 14.6.7. Koninklijke DSM N.V.
    • 14.6.8. MiMedx Group, Inc.

15. Strategic Recommendations